Publikationen

1. Kessler, C., Kwetkat, A., Meissner, F., Krusche, I., Bleidorn, J., Hartmann, M., Farker, K. Polypharmacy and unit dose dispensing system (UDDS) in geriatric care. Z Gerontol Geriat (2026). https://doi.org/10.1007/s00391-026-02595-w (IF: 1.100)

2. Janke F.F., Keßler C., Hartmann M., Baldessarini R.J., Farker, K. Drug therapy safety: methotrexate-associated medication errors. J Public Health, 2026, https://doi.org/10.1007/s10389-026-02857-2 (IF: 1.600)

3. Janke FF, Baldessarini RJ, Bauerschlag D, Zibolka S, Hartmann M. Health economic evaluation of Mirvetuximab soravtansine for the treatment of FRα-positive, platinum resistant ovarian cancer in Germany. J Cancer Res Clin Oncol 152, 111 (2026). https://doi.org/10.1007/s00432-026-06488-8 (IF: 3.300)

4. Karsten Dafonte, K., Lutz, P., Jansen, C., Busse, M., Dietrich, P., Farker, K., Lipp, H. P., Nattermann, J., Sauerbruch, T., Schmiedl, S., Strobach, D., Trebicka, J., Zocholl, D., Hartmann, G., Jaehde, U., Coenen, M. (2026). Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert Panel. Clinical drug investigation, 46(4), 377–390. ttps://doi.org/10.1007/s40261-026-01536-0 (IF: 3.100)

5. Schechner, M., Andrikyan, W., Bauerdick, T., Terstegen, T., Redeker, L., Federbusch, M., Farker, K., Strübing, A., Schmidt, F., Thürmann, P., Schmiedl, S., Seidling, H. M., Dreischulte, T., Neumann, D., Loeffler, M., Maas, R., Jaehde, U., Fromm, M. F., Sponfeldner, M. I.,INTERPOLAR project of the German Medical Informatics Initiative (2026). Development and analysis of a SmPC-based machine-readable dataset of contraindications for clinical decision support and real-world data analysis. European journal of clinical pharmacology, 82(8), 209. https://doi.org/10.1007/s00228-026-04142-3 (IF: 3.500)

1. Zubiria-Barrera C, Bos M, Neubert, Fiebig J, Lorenz M, Hartmann M, Mainz J, Slevogt H, Klassert T. Impact of Antibiotic Therapy on the Upper Respiratory Tract and Gut Mycobiome in Patients with Cystic Fibrosis. J. Fungi 2025, 11, 631. https://doi.org/10.3390/jof11090631. (IF: 4.000)

2. Kather, A., Arefian, H., Schneider, C., Hartmann, M., Runnebaum, I. B. (2025). Ovarian cancer prevention through opportunistic salpingectomy during abdominal surgeries: A cost-effectiveness modeling study. PLoS medicine, 22(1), e1004514. https://doi.org/10.1371/journal.pmed.1004514 (IF: 10.500)

3. Andrikyan, W., Sponfeldner, M. I., Jung-Poppe, L., Dürr, P., Straubmeier, M. I., Schuster, A. K., Weisbach, L., Farker, K., Hartmann, M., Fromm, M. F., Maas, R. (2025). Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics". British journal of clinical pharmacology, 91(3), 829–840. https://doi.org/10.1111/bcp.16331 (IF: 3.080)

4. Banz, M., Hagel, S., Sörgel, F., Kinzig, M., Farker, K., Pletz, M. W., Kentouche, K. (2025). Bridging to Transplant: TDM-guided Outpatient Dalbavancin Therapy in Chronic Granulomatous Disease With Deep-seeded Inoperable Abscesses Over 11 Months. Open forum infectious diseases, 12(5), ofaf260. https://doi.org/10.1093/ofid/ofaf260 (IF: 3.800)

5. Kiesel, J., Karsten-Dafonte, K., Farker, K., Koeck, J. A., Kessler, C., Strobach, D., Fischer, A. H., Wermund, A. M., Neumann, D. (2025). Concept of Modeling Pharmacist-Led Medication Reviews in Clinical Setting: A Knowledge Graph-Based Approach. Studies in health technology and informatics, 327, 168–172. https://doi.org/10.3233/SHTI250295  (IF: 0.000)

6. Wermund, A. M., Thalheim, T., Medek, A., Schmidt, F., Peschel, T., Strübing, A., Neumann, D., Scherag, A., Loeffler, M., Kesselmeier, M., Jaehde, U., POLAR_MI Consortium (2025). Challenges in detecting and predicting adverse drug events via distributed analysis of electronic health record data from German university hospitals. PLOS digital health, 4(6), e0000892. https://doi.org/10.1371/journal.pdig.0000892 (IF: 7.700)

7. Farker, K IM KONTEXT | Sulfonylharnstoffe für die Typ-2-Diabetes-Therapie Ist der Einsatz noch sinnvoll? Deutsches Ärzteblatt | Jg. 122 | Heft 18 | 5. September 2025 A 1036 Ist der Einsatz noch sinnvoll? (18) – Deutsches Ärzteblatt ePaper (IF: 0.000)

1. Schuster AK, Weisbach L, Kesselmeier M, Stumme C, Behringer W, Hartmann M, Farker K Characteristics Of Patients With Hospital Admission Due To Fall Events Identified Through Electronic Health Records Analysis. Journal of Public Health 2024. https://doi.org/10.1007/s10389-024-02366-0. (IF: 1,900)

2. Iffland, A., Zechel, M., Lewejohann, J. C., Edel, B., Hagel, S., Hartmann, M., Löffler, B., Rödel, J. (2024). Experience with PCR Testing for Enteric Bacteria and Viruses of Emergency Department Patients with Acute Gastroenteritis: Are There Implications for the Early Treatment of Clostridioides difficile Infection?. Antibiotics (Basel, Switzerland), 13(3), 243. https://doi.org/10.3390/antibiotics13030243 (IF: 4.800)

3. Loeffler, M., Maas, R., Neumann, D., Scherag, A., INTERPOLAR-Team (2024). INTERPOLAR – prospektive, interventionelle Studien im Rahmen der Medizininformatik-Initiative zur Verbesserung der Arzneimitteltherapiesicherheit in der Krankenversorgung [INTERPOLAR-prospective, interventional studies as part of the Medical Informatics Initiative to improve medication therapy safety in healthcare]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 67(6), 676–684. https://doi.org/10.1007/s00103-024-03890-w (IF: 1.600)

4. Dicheva-Radev S, Köberle U, Farker K, Bonnet U, Gundert-Remy U Falsch-positiver Test auf Amphetamin unter Methyldopa Bulletin zur Arzneimittelsicherheit 2024; 2:4-9 (IF: 0.000)

5. Dicheva-Radev S, Farker K Neue orale Kontrazeptiva: Faktencheck Arzneiverordnung in der Praxis 2024, Band 51, Heft 2, 162-175 (IF: 0.000)

1. Schuster, A. K., Weisbach, L., Kesselmeier, M., Stumme, C., Behringer, W., Hartmann, M., Farker, K. (2023). Sturzneigung und Verletzungen im Zusammenhang mit der COVID-19-Pandemie in einer Klinik für Notfallmedizin [Tendency to fall and injuries related to the Covid-19 pandemic at a department of emergency medicine]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 182-183, 26–31. https://doi.org/10.1016/j.zefq.2023.05.021 (IF: 1.100)

2. Weisbach, L., Schuster, A. K., Hartmann, M., Dürr, P., Then, M. I., Andrikyan, W., Fromm, M. F., Maas, R., Farker, K. (2023). Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs. British journal of clinical pharmacology, 89(8), 2552–2560. https://doi.org/10.1111/bcp.15730 (IF: 3.716)

1. Stallmach, A., Grunert, P., Stallhofer, J., Löffler, B., Baier, M., Rödel, J., Kiehntopf, M., Neugebauer, S., Pieper, D. H., Junca, H., Tannapfel, A., Merkel, U., Schumacher, U., Breternitz-Gruhne, M., Heller, T., Schauer, A., Hartmann, M., Steube, A. (2022). Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials, 23(1), 173. https://doi.org/10.1186/s13063-022-06095-1 (IF: 2.049)

2. Weisbach, L., Schuster, A. K., Hartmann, M., Fromm, M. F., Maas, R., Farker, K. (2022). Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications-A Systematic Analysis of SmPCs/PI of Major Drug Markets. Journal of clinical medicine, 11(7), 1933. https://doi.org/10.3390/jcm11071933 (IF: 4.964)

3. Schmidt, K. F. R., Huelle, K., Reinhold, T., Prescott, H. C., Gehringer, R., Hartmann, M., Lehmann, T., Mueller, F., Reinhart, K., Schneider, N., Schroevers, M. J., Kosilek, R. P., Vollmar, H. C., Heintze, C., Gensichen, J. S., The Smooth Study Group (2022). Healthcare Utilization and Costs in Sepsis Survivors in Germany-Secondary Analysis of a Prospective Cohort Study. Journal of clinical medicine, 11(4), 1142. https://doi.org/10.3390/jcm11041142 (IF: 4.242)

4. Schwarz, F., Arefian, H., Hartmann, M., Runnebaum, I. (2022). Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany. PloS one, 17(12), e0278460. https://doi.org/10.1371/journal.pone.0278460 (IF: 3.240)

1. Wolf C, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, Rengsberger M, Hartmann M, Hübner J. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment. Complementary and alternative medicine (CAM) supplements in cancer outpatients: analyses of usage and of interaction risks with cancer treatment, J Cancer Res Clin Oncol 2021. https://doi.org/10.1007/s00432-021-03675-7. (IF: 4.553)

2. Kruse HM, Helhorn A, Phan-Vogtmann LA, Palm J, Thomas E, Iffland A, Heidel A, Müller S, Saleh K, Krohn K, Specht M, Hartmann M, Farker K, Spreckelsen C, Henkel A, Scherag A, Ammon D. Integration of allergy documentation into an interoperable archiving and communication platform to improve patient care and clinical research at the Jena University Hospital. GMS Med Inform Biom Epidemiol 2021;17(2):Doc06(20210426). (If: 0,000)

3. Wolf C, Rachow T, Ernst T, Hochhaus A, Zomorodbakhsch B, Foller S, Rengsberger M, Hartmann M, Hübner J. Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements. J Cancer Res Clin Oncol (2021). https://doi.org/10.1007/s00432-021-03625-3. (IF: 4.553)

4. Häseler-Ouart, K., Arefian, H., Hartmann, M., Kwetkat, A. (2021). Geriatric assessment for older adults admitted to the emergency department: A systematic review and meta-analysis. Experimental gerontology, 144, 111184. https://doi.org/10.1016/j.exger.2020.111184 (IF: 3.376)

5. Farker K, Emons,G Arzneiwechselwirkungen zwischen Antibiotika und oralen Kontrazeptiva Arzneiverordnung in der Praxis 2021, Band 48, Heft 3-4, 94-99 (IF: 0.000)